{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T16:38:39Z","timestamp":1790354319394,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,13]],"date-time":"2025-09-13T00:00:00Z","timestamp":1757721600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.blre.2025.101338","type":"journal-article","created":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T14:46:44Z","timestamp":1757170004000},"page":"101338","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Metabolomics in sickle cell disease: Current knowledge and gaps \u2013 A scoping review"],"prefix":"10.1016","volume":"74","author":[{"given":"Sigrid","family":"van der Veen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith J.M.","family":"Jans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduard J.","family":"van Beers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart J.","family":"Biemond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Bartolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Paola","family":"Boaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Collado Gimbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Colombatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirco","family":"D'Agnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin J.","family":"Fijnvandraat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amira","family":"Idrizovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Kountouris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Ma\u00f1\u00fa Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Mezzalira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minke A.E.","family":"Rab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita W.","family":"Rijneveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Sanavia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanda M.","family":"Verhoeven-Duif","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjon H.","family":"Cnossen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.blre.2025.101338_bb0005","doi-asserted-by":"crossref","DOI":"10.1016\/S2352-3026(23)00118-7","article-title":"Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the global burden of disease study 2021","volume":"10","author":"Thomson","year":"2023","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.blre.2025.101338_bb0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2019.05.004","article-title":"Sickle cell disease: clinical presentation and management of a global health challenge","volume":"37","author":"Houwing","year":"2019","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2025.101338_bb0015","doi-asserted-by":"crossref","DOI":"10.1172\/JCI89741","article-title":"Intravascular hemolysis and the pathophysiology of sickle cell disease","volume":"127","author":"Kato","year":"2017","journal-title":"J Clin Investig"},{"key":"10.1016\/j.blre.2025.101338_bb0020","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2018.10","article-title":"Sickle cell disease","volume":"4","author":"Kato","year":"2018","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.blre.2025.101338_bb0025","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.22012","article-title":"Oxidative stress in sickle cell disease; pathophysiology and potential implications for disease management","volume":"86","author":"Nur","year":"2011","journal-title":"Am J Hematol"},{"issue":"6","key":"10.1016\/j.blre.2025.101338_bb0030","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/bjh.17524","article-title":"Dried blood spot metabolomics reveals a metabolic fingerprint with diagnostic potential for diamond Blackfan Anaemia","volume":"193","author":"van Dooijeweert","year":"2021","journal-title":"Br J Haematol"},{"issue":"10","key":"10.1016\/j.blre.2025.101338_bb0035","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.3324\/haematol.2020.266957","article-title":"Untargeted metabolic profiling in dried blood spots identifies disease fingerprint for pyruvate kinase deficiency","volume":"106","author":"van Dooijeweert","year":"2021","journal-title":"Haematologica"},{"issue":"3","key":"10.1016\/j.blre.2025.101338_bb0040","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/mas.21548","article-title":"Metabolomics toward personalized medicine","volume":"38","author":"Jacob","year":"2019","journal-title":"Mass Spectrom Rev"},{"issue":"35","key":"10.1016\/j.blre.2025.101338_bb0045","first-page":"4901","article-title":"Plasma metabolomic profiles enhance precision medicine for volunteers of normal health","volume":"112","author":"Guoa","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2025.101338_bb0050","doi-asserted-by":"crossref","DOI":"10.1002\/cfg.82","article-title":"Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks","volume":"2","author":"Fiehn","year":"2001","journal-title":"Comp Funct Genomics"},{"issue":"9","key":"10.1016\/j.blre.2025.101338_bb0055","doi-asserted-by":"crossref","DOI":"10.1016\/S0167-7799(98)01214-1","article-title":"Systematic functional analysis of the yeast genome","volume":"16","author":"Oliver","year":"1998","journal-title":"Trends Biotechnol"},{"key":"10.1016\/j.blre.2025.101338_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/nrm3314","article-title":"Innovation: metabolomics: the apogee of the omics trilogy","volume":"13","author":"Patti","year":"2012","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"16","key":"10.1016\/j.blre.2025.101338_bb0065","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1603023113","article-title":"Individual variability in human blood metabolites identifies age-related differences","volume":"113","author":"Chaleckis","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.blre.2025.101338_bb0070","first-page":"29","article-title":"Clinical and lifestyle related factors influencing whole blood metabolite levels \u2013 a comparative analysis of three large cohorts","author":"Beuchel","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/j.blre.2025.101338_bb0075","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1182\/bloodadvances.2018030619","article-title":"Metabolomic and molecular insights into sickle cell disease and innovative therapies","volume":"3","author":"Adebiyi","year":"2019","journal-title":"Blood Adv"},{"key":"10.1016\/j.blre.2025.101338_bb0080","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2006.01.010","article-title":"Sickle cell disease and nitric oxide: a paradigm shift?","volume":"38","author":"Kyle Mack","year":"2006","journal-title":"Int J Biochem Cell Biol"},{"issue":"4","key":"10.1016\/j.blre.2025.101338_bb0085","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1172\/JCI106294","article-title":"Effect of 2,3-diphosphoglycerate on oxygen affinity of blood in sickle cell anemia","volume":"49","author":"Charache","year":"1970","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.blre.2025.101338_bb0090","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1097\/XEB.0000000000000050","article-title":"Guidance for conducting systematic scoping reviews","volume":"13","author":"Peters","year":"2015","journal-title":"Int J Evid Based Healthc"},{"issue":"10","key":"10.1016\/j.blre.2025.101338_bb0095","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.11124\/JBIES-20-00167","article-title":"Updated methodological guidance for the conduct of scoping reviews","volume":"18","author":"Peters","year":"2020","journal-title":"JBI Evid Synth"},{"issue":"1","key":"10.1016\/j.blre.2025.101338_bb0100","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1080\/1364557032000119616","article-title":"Scoping studies: towards a methodological framework","volume":"8","author":"Arksey","year":"2005","journal-title":"Int J Soc Res Methodol Theory Pract"},{"key":"10.1016\/j.blre.2025.101338_bb0105","doi-asserted-by":"crossref","DOI":"10.7326\/M18-0850","article-title":"PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation","volume":"169","author":"Tricco","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.blre.2025.101338_bb0110","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.numecd.2021.01.008","article-title":"The evolving landscape of untargeted metabolomics","volume":"31","author":"Di Minno","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"issue":"6","key":"10.1016\/j.blre.2025.101338_bb0115","doi-asserted-by":"crossref","DOI":"10.1002\/hem3.109","article-title":"Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell disease","volume":"8","author":"van Dijk","year":"2024","journal-title":"Hemasphere"},{"issue":"3","key":"10.1016\/j.blre.2025.101338_bb0120","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.tracli.2010.06.011","article-title":"Metabolomic analysis of normal and sickle cell erythrocytes","volume":"17","author":"Darghouth","year":"2010","journal-title":"Transfus Clin Biol"},{"issue":"6","key":"10.1016\/j.blre.2025.101338_bb0125","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1182\/blood-2010-07-299636","article-title":"Pathophysiology of sickle cell disease is mirrored by the red blood cell metabolome","volume":"117","author":"Darghouth","year":"2011","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2025.101338_bb0130","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1111\/bjh.17315","article-title":"Blood plasma metabolomics of children and adolescents with sickle cell anaemia treated with hydroxycarbamide: a new tool for uncovering biochemical alterations","volume":"192","author":"Ribeiro","year":"2021","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2025.101338_bb0135","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.cca.2022.11.026","article-title":"Blood plasma and bone marrow interstitial fluid metabolomics of sickle cell disease patients with osteonecrosis: an exploratory study to dissect biochemical alterations","volume":"539","author":"Pereira","year":"2023","journal-title":"Clin Chim Acta"},{"issue":"12","key":"10.1016\/j.blre.2025.101338_bb0140","doi-asserted-by":"crossref","first-page":"3418","DOI":"10.3324\/haematol.2023.283288","article-title":"Metabolic signatures of cardiorenal dysfunction in plasma from sickle cell patients as a function of therapeutic transfusion and hydroxyurea treatment","volume":"108","author":"D\u2019Alessandro","year":"2023","journal-title":"Haematologica"},{"issue":"7","key":"10.1016\/j.blre.2025.101338_bb0145","article-title":"In vivo evaluation of the effect of sickle cell hemoglobin S, C and therapeutic transfusion on erythrocyte metabolism and cardiorenal dysfunction","volume":"98","author":"D\u2019Alessandro","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2025.101338_bb0150","article-title":"Potential causal role of L-glutamine in sickle cell disease painful crises: a Mendelian randomization analysis","volume":"86","author":"Iboudo","year":"2021","journal-title":"Blood Cells Mol Dis"},{"issue":"12","key":"10.1016\/j.blre.2025.101338_bb0155","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/ajh.25263","article-title":"Clinical and metabolomic risk factors associated with rapid renal function decline in sickle cell disease","volume":"93","author":"Xu","year":"2018","journal-title":"Am J Hematol"},{"key":"10.1016\/j.blre.2025.101338_bb0160","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/bjh.15592","article-title":"Plasma metabolomics analysis in sickle cell disease patients with albuminuria \u2013 an exploratory study","volume":"185","author":"Elsherif","year":"2019","journal-title":"Br J Haematol"},{"issue":"4","key":"10.1016\/j.blre.2025.101338_bb0165","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/jcm9041092","article-title":"Sickle cell disease: metabolomic profiles of VASO-occlusive crisis in plasma and erythrocytes","volume":"9","author":"Demb\u00e9l\u00e9","year":"2020","journal-title":"J Clin Med"},{"issue":"1\u20132","key":"10.1016\/j.blre.2025.101338_bb0170","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.ymgme.2022.08.004","article-title":"Amino acid signature during sickle cell pain crisis shows significant alterations related to nitric oxide and energy metabolism","volume":"137","author":"Zhou","year":"2022","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.blre.2025.101338_bb0175","first-page":"1","article-title":"Sickle cell anaemia therapy in 2025","volume":"00","author":"Schechter","year":"2024","journal-title":"Br J Haematol"},{"key":"10.1016\/j.blre.2025.101338_bb0180","article-title":"Sickle cell drug is withdrawn over safety concerns just months after rollout","volume":"387","author":"Mahase","year":"2024","journal-title":"BMJ"},{"issue":"24","key":"10.1016\/j.blre.2025.101338_bb0185","doi-asserted-by":"crossref","DOI":"10.1182\/bloodadvances.2023011477","article-title":"One-year safety and efficacy of mitapivat in sickle cell disease: follow-up results of a phase 2, open-label study","volume":"7","author":"van Dijk","year":"2023","journal-title":"Blood Adv"},{"issue":"Supplement 1","key":"10.1016\/j.blre.2025.101338_bb0190","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1182\/blood-2024-204962","article-title":"Etavopivat reduces incidence of vaso-occlusive crises in patients with sickle cell disease: HIBISCUS trial phase 2 results through 52 weeks","volume":"144","author":"Delicou","year":"2024","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2025.101338_bb0195","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1111\/trf.14931","article-title":"Effects of red blood cell (RBC) transfusion on sickle cell disease recipient plasma and RBC metabolism","volume":"58","author":"Culp-Hill","year":"2018","journal-title":"Transfusion (Paris)"},{"issue":"10","key":"10.1016\/j.blre.2025.101338_bb0200","doi-asserted-by":"crossref","first-page":"3102","DOI":"10.1111\/trf.15467","article-title":"Metabolic impact of red blood cell exchange with rejuvenated red blood cells in sickle cell patients","volume":"59","author":"Gehrke","year":"2019","journal-title":"Transfusion (Paris)"},{"key":"10.1016\/j.blre.2025.101338_bb0205","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2023.101103","article-title":"Activation of pyruvate kinase as therapeutic option for rare hemolytic anemias: shedding new light on an old enzyme","volume":"61","author":"van Dijk","year":"2023","journal-title":"Blood Rev"},{"key":"10.1016\/j.blre.2025.101338_bb0210","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.26554","article-title":"Safety and efficacy of mitapivat, an oral pyruvate kinase activator, in sickle cell disease: a phase 2, open-label study","volume":"97","author":"van Dijk","year":"2022","journal-title":"Am J Hematol"},{"issue":"19","key":"10.1016\/j.blre.2025.101338_bb0215","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood.2022015403","article-title":"A phase 1 dose escalation study of the pyruvate kinase activator mitapivat (AG-348) in sickle cell disease","volume":"140","author":"Xu","year":"2022","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2025.101338_bb0220","first-page":"2639","article-title":"Functional and multi-omics signatures of mitapivat efficacy upon activation of pyruvate kinase in red blood cells from patients with sickle cell disease","volume":"109","author":"D\u2019Alessandro","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.blre.2025.101338_bb0225","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4397150","article-title":"Double-blind clinical trial of arginine supplementation in the treatment of adult patients with sickle cell anaemia","volume":"2019","author":"Eleut\u00e9rio","year":"2019","journal-title":"Adv Hematol"},{"issue":"9","key":"10.1016\/j.blre.2025.101338_bb0230","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.3324\/haematol.2013.086637","article-title":"A randomized, placebo-controlled trial of arginine therapy for the treatment of children with sickle cell disease hospitalized with vaso-occlusive pain episodes","volume":"98","author":"Morris","year":"2013","journal-title":"Haematologica"},{"issue":"1","key":"10.1016\/j.blre.2025.101338_bb0235","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1002\/ajh.26028","article-title":"Randomized control trial of oral arginine therapy for children with sickle cell anemia hospitalized for pain in Nigeria","volume":"96","author":"Onalo","year":"2021","journal-title":"Am J Hematol"},{"issue":"supplement 1","key":"10.1016\/j.blre.2025.101338_bb0240","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1182\/blood-2022-156577","article-title":"Impact of arginine therapy on mitochondrial function in children with sickle cell disease during vaso-occlusive pain","volume":"140","author":"Morris","year":"2020","journal-title":"Blood"},{"issue":"10","key":"10.1016\/j.blre.2025.101338_bb0245","article-title":"Oral citrulline as arginine precursor may be beneficial in sickle cell disease: early phase two results","volume":"93","author":"Waugh","year":"2001","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"10.1016\/j.blre.2025.101338_bb0250","article-title":"Hypoxia-mediated impaired erythrocyte lands\u2019 cycle is pathogenic for sickle cell disease","volume":"6","author":"Wu","year":"2016","journal-title":"Sci Rep"},{"issue":"8 August","key":"10.1016\/j.blre.2025.101338_bb0255","article-title":"The gut microbiome in sickle cell disease: characterization and potential implications","volume":"16","author":"Brim","year":"2021","journal-title":"PloS One"},{"issue":"8","key":"10.1016\/j.blre.2025.101338_bb0260","doi-asserted-by":"crossref","DOI":"10.1681\/ASN.2012101006","article-title":"A combined epidemiologic and metabolomic approach improves CKD prediction","volume":"24","author":"Rhee","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"10.1016\/j.blre.2025.101338_bb0265","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-022-01954-z","article-title":"Metabolomic profiling for dyslipidemia in pediatric patients with sickle cell disease, on behalf of the IHCC consortium","volume":"18","author":"Qu","year":"2022","journal-title":"Metabolomics"},{"issue":"3","key":"10.1016\/j.blre.2025.101338_bb0270","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032529","article-title":"Comparison between sickle cell disease patients and healthy donors: untargeted lipidomic study of erythrocytes","volume":"24","author":"Alabed","year":"2023","journal-title":"Int J Mol Sci"},{"issue":"3","key":"10.1016\/j.blre.2025.101338_bb0275","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2141.2010.08109.x","article-title":"Lipid levels in sickle-cell disease associated with haemolytic severity, vascular dysfunction and pulmonary hypertension","volume":"149","author":"Zorca","year":"2010","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2025.101338_bb0280","doi-asserted-by":"crossref","DOI":"10.4103\/0300-1652.140388","article-title":"Defective lipid metabolism in sickle cell anaemia subjects in vaso-occlusive crisis","volume":"55","author":"Akinlade","year":"2014","journal-title":"Niger Med J"},{"issue":"7","key":"10.1016\/j.blre.2025.101338_bb0285","doi-asserted-by":"crossref","DOI":"10.1007\/s11306-021-01813-3","article-title":"Comparison of dried blood spot and plasma sampling for untargeted metabolomics","volume":"17","author":"Tobin","year":"2021","journal-title":"Metabolomics"},{"key":"10.1016\/j.blre.2025.101338_bb0290","doi-asserted-by":"crossref","DOI":"10.1093\/jpepsy\/jsv084","article-title":"Systematic and meta-analytic review: medication adherence among pediatric patients with sickle cell disease","volume":"41","author":"Loiselle","year":"2016","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/j.blre.2025.101338_bb0295","doi-asserted-by":"crossref","DOI":"10.1097\/HS9.0000000000000844","article-title":"Challenges and opportunities of precision medicine in sickle cell disease: novel European approach by GenoMed4All Consortium and ERN-EuroBloodNet","volume":"7","author":"Collado","year":"2023","journal-title":"HemaSphere"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X25000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X25000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T17:32:13Z","timestamp":1766079133000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X25000839"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":59,"alternative-id":["S0268960X25000839"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2025.101338","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolomics in sickle cell disease: Current knowledge and gaps \u2013 A scoping review","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2025.101338","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101338"}}